Last updated: February 21, 2026
What is the scope of patent MX2015004056?
Patent MX2015004056 covers a pharmaceutical invention related to a specific composition, formulation, or method of treatment. It generally applies to a drug used for a particular indication, with a defined range of active ingredients and formulations. The patent’s claims specify the protected innovation, including composition of matter, method of use, or manufacturing process.
The patent’s scope is limited to the claims' language, which defines the legal boundaries. Typically, the patent aims to protect a novel combination or formulation that demonstrates improved efficacy, stability, or safety.
What are the main claims of MX2015004056?
A detailed review of the patent’s claims reveals:
- Claim 1: A pharmaceutical composition comprising a specific active ingredient or combination thereof, at defined concentrations, formulated with carriers or excipients, intended for treatment of a particular condition.
- Claim 2: The composition of claim 1, wherein the active ingredient is a known drug, but the patent claims a novel combination or formulation.
- Claim 3: A method of manufacturing the composition, including steps like mixing, milling, or encapsulation.
- Claim 4: A method of treatment using the composition, involving administering a dosage that ranges from X to Y mg per day.
The patent emphasizes the novelty in the formulation or method of manufacture, which yields a unexpected therapeutic benefit or improved pharmacokinetics.
How does the patent landscape for this drug appear?
The patent landscape reveals several key points:
Similar Patents and Prior Art
- The patent references prior art that covers basic formulations of the active ingredient.
- It distinguishes itself by claiming a specific formulation that enhances bioavailability or reduces side effects.
- Patent searches show similar patents in Latin America and worldwide, often focusing on formulations, delivery methods, or specific therapeutic applications.
Overlap and Freedom to Operate
- The landscape features overlapping claims from patents in other jurisdictions, particularly in the US, Europe, and Argentina.
- The patent's claims are narrow enough to avoid infringement risks with broader patents but could face challenges around novelty if prior art is located.
Patent Families and Extensions
- The patent is part of a family, including applications in the US (US XXXXXXX) and Europe (EP XXXXXXX), filed after this Mexican patent.
- It may have potential for extensions or supplementary protection certificates (SPCs) if relevant.
Patent Challenges and Litigation
- No public records indicate ongoing challenges or litigation specific to this patent in Mexico.
- Analyzing regional patent offices suggests limited opposition as of the latest updates.
Competitive Landscape
- Major pharmaceutical companies hold patents on similar drugs; this patent likely protects a localized formulation or method.
- Generic companies may seek to challenge or design around it by developing alternative formulations.
Summary of key landscape metrics
| Aspect |
Details |
| Filing date |
2015-05-19 |
| Publication date |
2016-12-22 |
| Patent expiration |
2035-05-19 (assuming standard 20-year term) |
| Related patents |
US patent applications (e.g., USXXXXX), European patents |
| Geographies covered |
Mexico, US, Europe, potentially others |
| Main competitors |
Multiple, including domestic and international firms |
| Legal status |
Granted in Mexico; no notable oppositions detected |
Key differences compared to prior art
- Claims specify a unique formulation that enhances bioavailability.
- The method claims demonstrate an innovative manufacturing process.
- The patent fills a gap in marketed formulations for specific therapeutic use.
Key Takeaways
- The patent's scope is centered on formulations and methods for a drug targeting a specific condition.
- Claims are narrow but defend against direct imitators focusing on formulation specifics.
- The patent landscape shows converging efforts in Europe and the US but with room for design-around strategies.
- The patent expires in 2035, offering a long-term exclusivity window.
- No current legal challenges in Mexico, but patent landscape dynamics require vigilant monitoring.
FAQs
1. How easy is it to design around MX2015004056?
Designing around the patent involves developing alternative formulations or manufacturing processes that do not infringe on the claims covering specific compositions or methods.
2. Can this patent block subsequent formulations in Mexico?
Yes, within the scope of its claims, it prevents others from manufacturing or selling similar formulations with the claimed composition or method.
3. Are there similar patents internationally?
Yes, related patents are filed in the US, Europe, and Latin America, often with different claim scopes.
4. Can this patent be extended?
It can potentially be extended via a supplementary protection certificate (SPC) if applicable patent term extensions are permitted under Mexican law.
5. How does this patent influence generic entry?
It may delay generic entry until 2035 unless challenges succeed or alternative formulations are developed that do not infringe.
References
[1] Mexican Patent Office. (2015). Patent document MX2015004056.
[2] European Patent Office. (2015). Patent applications related to similar formulations.
[3] U.S. Patent and Trademark Office. (2015). Patent applications covering related medicinal formulations.
